reagents
With Oxford Nanopore Technologies' new R10.4 flow cell and chemistry, researchers generated near-finished microbial genomes using only nanopore long-read sequencing.
The firm plans to submit at least three diagnostic assays to the FDA in the upcoming fiscal year, in addition to five life sciences products.
Illumina blamed "manufacturing and supplier capacity constraints" for weekslong delays seen on orders for certain sequencing reagent kits.
Illumina Q4 Revenues Flat, 2020 Revenues Down 9 Percent
The company's fourth quarter and full-year revenues of $953 million and $3.24 billion, respectively, matched estimates released last month.
Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company
The CRISPR-based test uses Mammoth's DETECTR BOOST platform and will be compatible with both nasal swab and saliva samples.